In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

AstraZeneca (AZN) stock is in focus as the company's experimental drug gefurulimab for generalized myasthenia gravis hits Phase 3 trial goals. Read more here.

AstraZeneca plans to invest $50 billion in U.S. operations by 2030, including a new facility in Virginia. Petersburg, Virginia is a potential location for the new AstraZeneca facility due to its ...

Youngkin boasts Virginia's shovel-ready sites and workforce as key in luring AstraZeneca AstraZeneca selected Virginia for its largest global manufacturing investment, boosting local job prospects.

Ahead of the 10-year anniversary of Tagrisso’s FDA approval this fall, AstraZeneca has debuted the first DTC commercial for the lung cancer med.

AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about tariffs loom over the industry.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs.

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid US leader Donald Trump's threats to impose tariffs on the sector.

China is being viewed by the biotech and life sciences industry as a threat to US innovation. One pharma CEO thinks it may not be the worst thing to happen to the industry.